Skin Pharm's Boston page now reads “OPENS THURSDAY, 11/12” — the Nashville-based aesthetic skin care chain is scheduled to open on Newbury Street, offering Botox and Dysport, PRP therapy, filler and microneedling among its treatments, according to Skin Pharm. New patients can book with the code NEWINBOS for 20% off their first treatment, and the clinic's founding special includes a complimentary skin consultation valued at $150.
The Boston location will mark Skin Pharm's first foray into the Northeast, according to WWD, which reported the company now operates 18 clinics nationwide, including locations across Georgia, Virginia, Texas, North Carolina, South Carolina, Illinois, Tennessee and Florida. Brad Griffin, president of Skin Pharm, told the outlet the company chose Boston partly because of a strong existing social media following in the city, along with notable online skin care sales demand from Massachusetts and the broader Northeast region.
Earlier reporting had flagged the project while it was still in the planning stages. The Boston Sun reported in April that the company intended to open in a third-floor space at 149 Newbury St., with proposed hours of 8:30 a.m. to 5 p.m. Monday through Friday and six to eight employees, including a medical professional. That report also noted the project required the city's Board of Appeal to approve a change in occupancy from office/retail to clinical space.
Another Greater Boston Clinic Planned
Another branded clinic has announced a planned Greater Boston location: Neem Medical Spa said it expected to open in Chestnut Hill in July 2026. The company described the site as offering physician-led aesthetic, longevity and wellness care, a broader stated scope than Skin Pharm's Newbury Street treatment menu, which includes injectables and skin procedures, according to Neem Medical Spa's announcement.
From Nashville Startup to National Chain
Skin Pharm was founded by Maegan Griffin, a board-certified nurse practitioner, who opened the company's first clinic in 2017 and introduced its product line the following year, WWD reported.
WWD reported that Skin Pharm's providers include certified nurse practitioners and physician assistants, and that patients are seen by their provider rather than a medical assistant.
Products and Treatments on the Menu
Skin Pharm's menu extends beyond injectables to platelet-rich plasma therapy, microneedling, facial balancing and a treatment the company calls gold infusion. WWD reported that the clinic chain also sells its own skin care products, including cleansers, serums, toners, masks and moisturizers.
The planned Boston opening follows Prelude Growth Partners' announcement three years earlier of a $15 million minority investment in Skin Pharm. The female-founded growth equity firm said at the time that the funding would support the company's nationwide clinic expansion plans and contribute to ongoing product development, according to Prelude's announcement. The firm's statement noted that Maegan Griffin would continue to lead the company following the investment.
More Clinics on the Way
Skin Pharm plans to open three additional locations in the first half of 2027 as it continues to expand across the West Coast, Southeast and Midwest, WWD reported, though plans for the second half of the year have not yet been finalized. The company also intends to introduce new product offerings, per the same report.
The scheduled Boston debut comes amid broader growth across the medical aesthetics industry, which has surpassed $17 billion nationally and is growing by more than $1 billion per year, as reported by American Med Spa Association — though the association's report offers only national figures and does not drill down to state or city data. A separate analysis of more than 100 medspa brands found median practice revenue grew 19.2% year over year in the first half of 2026, even as median new-patient growth was just 1.2%, as noted by American Med Spa Association, suggesting much of the industry's expansion is coming from existing clients spending more rather than from a flood of newcomers.
That dynamic has also drawn outside investors to rival chains. Prelude's announcement pointed to med spa Ever/Body, which raised a $38 million Series B and later a $55.5 million Series C, as well as KKR's minority stake in SkinSpirit, which the firm described as the country's largest provider of Botox and filler. Investors have also backed booking infrastructure for the sector: Upkeep, an app for finding, booking and paying for med spa treatments, secured $2 million in seed funding the year before Prelude's Skin Pharm investment was announced.
